» Articles » PMID: 37468850

Identification of Cell Subpopulations Associated with Disease Phenotypes from ScRNA-seq Data Using PACSI

Overview
Journal BMC Biol
Publisher Biomed Central
Specialty Biology
Date 2023 Jul 19
PMID 37468850
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Single-cell RNA sequencing (scRNA-seq) has revolutionized the transcriptomics field by advancing analyses from tissue-level to cell-level resolution. Despite the great advances in the development of computational methods for various steps of scRNA-seq analyses, one major bottleneck of the existing technologies remains in identifying the molecular relationship between disease phenotype and cell subpopulations, where "disease phenotype" refers to the clinical characteristics of each patient sample, and subpopulation refer to groups of single cells, which often do not correspond to clusters identified by standard single-cell clustering analysis. Here, we present PACSI, a method aimed at distinguishing cell subpopulations associated with disease phenotypes at the single-cell level.

Results: PACSI takes advantage of the topological properties of biological networks to introduce a proximity-based measure that quantifies the correlation between each cell and the disease phenotype of interest. Applied to simulated data and four case studies, PACSI accurately identified cells associated with disease phenotypes such as diagnosis, prognosis, and response to immunotherapy. In addition, we demonstrated that PACSI can also be applied to spatial transcriptomics data and successfully label spots that are associated with poor survival of breast carcinoma.

Conclusions: PACSI is an efficient method to identify cell subpopulations associated with disease phenotypes. Our research shows that it has a broad range of applications in revealing mechanistic and clinical insights of diseases.

Citing Articles

Biases in machine-learning models of human single-cell data.

Willem T, Shitov V, Luecken M, Kilbertus N, Bauer S, Piraud M Nat Cell Biol. 2025; 27(3):384-392.

PMID: 39972066 DOI: 10.1038/s41556-025-01619-8.


DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer.

Liu C, Zhang Y, Liang Y, Zhang T, Wang G Brief Bioinform. 2024; 25(6).

PMID: 39350337 PMC: 11442150. DOI: 10.1093/bib/bbae490.


Exploring the Expression and Function of T Cell Surface Markers Identified through Cellular Indexing of Transcriptomes and Epitopes by Sequencing.

Hwang J, Kim Y, Na K, Kim D, Lee S, Kang S Yonsei Med J. 2024; 65(9):544-555.

PMID: 39193763 PMC: 11359606. DOI: 10.3349/ymj.2023.0639.

References
1.
Riaz M, Sieuwerts A, Look M, Timmermans M, Smid M, Foekens J . High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes. Breast Cancer Res. 2012; 14(5):R123. PMC: 4053101. DOI: 10.1186/bcr3317. View

2.
Yang B, Liu H, Bi Y, Cheng C, Li G, Kong P . MYH9 promotes cell metastasis inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma. Int J Med Sci. 2020; 17(13):2013-2023. PMC: 7415390. DOI: 10.7150/ijms.46234. View

3.
Song G, Sun Y, Shen H, Li W . SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients. Tumour Biol. 2015; 36(6):4167-73. DOI: 10.1007/s13277-015-3051-9. View

4.
Xu Y, Qin L, Sun T, Wu H, He T, Yang Z . Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression. Oncogene. 2016; 36(8):1157-1166. PMC: 5311074. DOI: 10.1038/onc.2016.286. View

5.
Newman A, Liu C, Green M, Gentles A, Feng W, Xu Y . Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015; 12(5):453-7. PMC: 4739640. DOI: 10.1038/nmeth.3337. View